The serpinopathies are among a diverse set of conformational diseases that involve the aberrant self-association of proteins into ordered aggregates. α1-Antitrypsin deficiency is the archetypal serpinopathy and results from the formation and deposition of mutant forms of α1-antitrypsin as “polymer” chains in liver tissue. No detailed structural analysis has been performed of this material. Moreover, there is little information on the relevance of well-studied artificially induced polymers to these disease-associated molecules. We have isolated polymers from the liver tissue of Z α1-antitrypsin homozygotes (E342K) who have undergone transplantation, labeled them using a Fab fragment, and performed single-particle analysis of negative-stain e...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
The serpinopathies result from point mutations in members of the serine protease inhibitor or serpin...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...
The serpinopathies are among a diverse set of conformational diseases that involve the aberrant self...
α1-Antitrypsin is an abundant plasma inhibitor of neutrophil elastase,expressed at high levels by he...
The formation of ordered Z (Glu342Lys) α1 -antitrypsin polymers in hepatocytes is central to liver d...
The serpinopathies result from the ordered polymerization of mutants of members of the serine protei...
The serpinopathies result from the ordered polymerization of mutants of members of the serine protei...
AbstractEmphysema and liver cirrhosis can be caused by the Z mutation (Glu342Lys) in the serine prot...
α1-Proteinase inhibitor (antitrypsin) is a canonical example of the serpin family member that binds ...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
<div><p>α<sub>1</sub>-Proteinase inhibitor (antitrypsin) is a canonical example of the serpin family...
The serpinopathies result from point mutations in members of the serine protease inhibitor or serpin...
AbstractAlpha1-antitrypsin deficiency results from point mutations that distort the structure of the...
Protein misfolding is associated with a range of diseases and occurs when a protein meanders from it...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
The serpinopathies result from point mutations in members of the serine protease inhibitor or serpin...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...
The serpinopathies are among a diverse set of conformational diseases that involve the aberrant self...
α1-Antitrypsin is an abundant plasma inhibitor of neutrophil elastase,expressed at high levels by he...
The formation of ordered Z (Glu342Lys) α1 -antitrypsin polymers in hepatocytes is central to liver d...
The serpinopathies result from the ordered polymerization of mutants of members of the serine protei...
The serpinopathies result from the ordered polymerization of mutants of members of the serine protei...
AbstractEmphysema and liver cirrhosis can be caused by the Z mutation (Glu342Lys) in the serine prot...
α1-Proteinase inhibitor (antitrypsin) is a canonical example of the serpin family member that binds ...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
<div><p>α<sub>1</sub>-Proteinase inhibitor (antitrypsin) is a canonical example of the serpin family...
The serpinopathies result from point mutations in members of the serine protease inhibitor or serpin...
AbstractAlpha1-antitrypsin deficiency results from point mutations that distort the structure of the...
Protein misfolding is associated with a range of diseases and occurs when a protein meanders from it...
Alpha(1)-antitrypsin is the most abundant circulating protease inhibitor. The severe Z deficiency al...
The serpinopathies result from point mutations in members of the serine protease inhibitor or serpin...
α1-Antitrypsin is primarily synthesised in the liver, circulates to the lung and protects pulmonary ...